Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.404 Factor de Impacto de 5 años: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumes:
Volumen 40, 2020 Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v15.i3-4.70
pages 317-348

The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins

Denis P. Snider
Department of Pathology, HSC-3N26H, McMaster University, 1200 Main St. W., Hamilton, Ontario, Canada L8N 3Z5

SINOPSIS

The bacterial enterotoxins, cholera toxin and the heat labile toxin of E. coli, are well known adjuvants for mucosal immune response. Their common A chain mediates the toxigenic mechanism by causing ADP ribosylation of G proteins and subsequent elevation of cAMP in target cells. A large IgA and IgG antibody response to admixed protein antigen (Ag) is the hallmark of these adjuvants and is clearly associated with the A chain activity. Expansion of Ag-specific B and T cells, alteration of T cell cytokine production, and changes in regulatory T cells have been reported as adjuvant mechanisms. The B chain derivatives of these toxins can also weakly enhance immune response, especially if covalently associated with Ag and used for nasophyrangeal immunization. Importantly, these toxins or their B chain derivatives can alter the normal immune regulation that produces oral tolerance. This indicates that they modulate mechanisms operative between the mucosal and systemic immune systems. There are some discrepancies between in vitro models of CT or LT activity and in vivo manifestations of their adjuvant activities. Interpretation of current data regarding in vivo mechanism is hampered by an incomplete understanding of how mucosal B and T cells can interact with systemic lymphoid tissue and vice versa. More important, there is no clear understanding of the early effects of the toxins on the local (and draining) mucosal lymphoid tissues. This is especially true in the critical areas of antigen presentation, T and B cell activation, and cytokine production.


Articles with similar content:

The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins
Critical Reviews™ in Immunology, Vol.37, 2017, issue 2-6
Denis P. Snider
CD14+ Monocytes as Dendritic Cell Precursors: Diverse Maturation-Inducing Pathways Lead to Common Activation of NF-kB/RelB
Critical Reviews™ in Immunology, Vol.21, 2001, issue 1-3
Peter A. Cohen, Gary K. Koski, Lyudmila A. Lyakh, Nancy R. Rice
Transcriptional Regulation of IL-10 and Its Cell-Specific Role In Vivo
Critical Reviews™ in Immunology, Vol.34, 2014, issue 4
J. Simon C. Arthur, Kirsty F. MacKenzie, Michael J. Pattison
MAIT Cells in COVID-19: Heroes, Villains, or Both?
Critical Reviews™ in Immunology, Vol.40, 2020, issue 2
S. M. Mansour Haeryfar
Regulation of Class II MHC Expression
Critical Reviews™ in Immunology, Vol.16, 1996, issue 3
Etty N Benveniste, Yi-Ju Lee, Wolfgang M. Rohn